Bruker, Kiestra Ink Co-marketing Pact for Microbiology Mass Spec System | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker Daltonics and Kiestra Lab Automation said today that they have expanded a co-marketing and cross-selling partnership covering the use of their technologies in microbiology laboratories.

The companies have also signed a research and development agreement to integrate Bruker's MALDI Biotyper and Kiestra’s MalditofA, an automatic colony picker.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.